Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective

Joshua Iseoluwa Orege, Sherif Babatunde Adeyemi, Bashir Bolaji Tiamiyu, Toluwanimi Oluwadara Akinyemi, Yusuf Ajibola Ibrahim, Odunola Blessing Orege

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Abstract

The search for a potent anti-coronavirus therapy for severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) remains an overwhelming task since the outbreak of COVID-19. It is more evident that most of the existing antiviral and immune-boosting drugs are non-promising and ineffective for the treatment of coronavirus infected patients while the safety of a few drugs/vaccines that have demonstrated high potential remains unclear. With daily records of confirmed infectious cases across the world, it is crucial to emphasize the need for repurposed therapies with a validated ethnomedicinal base focused on well-known active medicines with traceable biochemical, pharmacological and safety profiles for viral infection management. In the present study, recent literature on Artemisia and Artemisia-based products for the management of COVID-19 are reviewed. Artemisia-based products have demonstrated a broad spectrum of biological ability including antiviral properties. Besides its antiviral activity, Artemisia annua have shown to contain appreciable amounts of minerals such as zinc, gallium and selenium among others. Graphic abstract: [Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)85-96
Number of pages12
JournalAdvances in Traditional Medicine
Volume23
Issue number1
DOIs
StatePublished - Mar 2023
Externally publishedYes

Keywords

  • Anti-inflammation
  • Artemisia
  • Artemisia derivatives
  • Clinical trials
  • COVID-19
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective'. Together they form a unique fingerprint.

Cite this